Match each pediatric patient presenting with suspected osteoarticular or disseminated infection to the most appropriate initial empiric antimicrobial regimen based on their specific clinical risk factors.
- A 6-year-old boy with sickle cell disease presenting with acute-onset fever, severe focal tibial tenderness, and localized swelling.Intravenous vancomycin and ceftriaxone
- A 14-year-old boy presenting with a hot, erythematous, and swollen foot 5 days after sustaining a deep puncture wound through a rubber-soled athletic shoe.Intravenous vancomycin and cefepime
- A 3-week-old neonate born at term presenting with a temperature of 38.6°C (101.5°F), extreme irritability, and decreased spontaneous movement of the right leg (pseudoparalysis).Intravenous vancomycin and cefotaxime
- A 16-year-old sexually active female presenting with an acutely swollen knee, tenosynovitis of the right wrist, and a scattered vesiculopustular rash on her extremities.Intravenous ceftriaxone
Answer
The sickle cell patient matches to vancomycin/ceftriaxone; the sneaker puncture patient to vancomycin/cefepime; the neonate to vancomycin/cefotaxime; and the adolescent with the vesiculopustular rash to ceftriaxone alone.
Empiric antimicrobial therapy in pediatric infectious diseases requires synthesizing the patient's age, underlying medical conditions, and mechanism of injury to predict the most likely pathogens. While Staphylococcus aureus is the most common cause of pediatric osteomyelitis overall, special populations require tailored additions: Salmonella (sickle cell), Pseudomonas (sneaker puncture), and enteric Gram-negatives/GBS (neonates). Furthermore, age-specific contraindications (like avoiding ceftriaxone in neonates) must dictate the exact cephalosporin chosen.
Step-by-Step Solution
Key Concept
Empiric Antimicrobial Selection for Pediatric Osteoarticular Infections Based on Risk Factors